Growth Metrics

Spero Therapeutics (SPRO) Shares Issued (2018 - 2023)

Historic Shares Issued for Spero Therapeutics (SPRO) over the last 6 years, with Q4 2023 value amounting to $1000.0.

  • Spero Therapeutics' Shares Issued rose 10001.01% to $1000.0 in Q4 2023 from the same period last year, while for Dec 2024 it was $221000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $221000.0 for FY2023, which is 4738.1% down from last year.
  • According to the latest figures from Q4 2023, Spero Therapeutics' Shares Issued is $1000.0, which was up 10001.01% from $220000.0 recorded in Q3 2023.
  • In the past 5 years, Spero Therapeutics' Shares Issued ranged from a high of $40.0 million in Q2 2021 and a low of -$38.9 million during Q3 2021
  • Moreover, its 5-year median value for Shares Issued was $2.8 million (2020), whereas its average is $3.9 million.
  • In the last 5 years, Spero Therapeutics' Shares Issued surged by 487894.74% in 2020 and then plummeted by 215581.4% in 2021.
  • Quarter analysis of 5 years shows Spero Therapeutics' Shares Issued stood at $5.5 million in 2019, then decreased by 27.23% to $4.0 million in 2020, then crashed by 197.6% to -$3.9 million in 2021, then crashed by 153.75% to -$9.9 million in 2022, then surged by 100.01% to $1000.0 in 2023.
  • Its Shares Issued was $1000.0 in Q4 2023, compared to $220000.0 in Q3 2023 and -$9.9 million in Q4 2022.